Pascal Touchon
President and CEO at Atara Biotherapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Atara Biotherapeutics Inc., 3 years.
Atara Biotherapeutics Inc.
Director · President and CEO
Chief executive roles
Atara Biotherapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 16, 2024 | Atara Biotherapeutics Inc. | Open-market sale | −81,506 | $0.62 | $50,534 |
| Mar 4, 2024 | Atara Biotherapeutics Inc. | Open-market sale | −24,844 | $0.72 | $17,888 |
| Jan 8, 2024 | Atara Biotherapeutics Inc. | Grant or award | +1,280,000 | — | — |
| Nov 16, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −20,409 | $0.39 | $7,960 |
| Aug 16, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −21,432 | $1.65 | $35,363 |
| Aug 16, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −9,334 | $1.65 | $15,401 |
| Jun 27, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −14,291 | $1.66 | $23,723 |
| May 16, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −29,766 | $2.04 | $60,723 |
| Mar 2, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −15,679 | $3.63 | $56,915 |
| Mar 1, 2023 | Atara Biotherapeutics Inc. | Grant or award | +324,711 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.